The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin lar     Quarter: 2016Q3

Total Records: 1,320     Number of Pages: 66

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Upper limb fracture 7
SANDOSTATIN LAR DEPOT Uterine neoplasm 7
SANDOSTATIN LAR DEPOT Vulvovaginal mycotic infection 7
SANDOSTATIN LAR DEPOT Weight gain poor 7
SANDOSTATIN LAR DEPOT Adenocarcinoma 6
SANDOSTATIN LAR DEPOT Affect lability 6
SANDOSTATIN LAR DEPOT Affective disorder 6
SANDOSTATIN LAR DEPOT Agitation 6
SANDOSTATIN LAR DEPOT Application site mass 6
SANDOSTATIN LAR DEPOT Basal cell carcinoma 6
SANDOSTATIN LAR DEPOT Biliary dilatation 6
SANDOSTATIN LAR DEPOT Blood disorder 6
SANDOSTATIN LAR DEPOT Blood electrolytes abnormal 6
SANDOSTATIN LAR DEPOT Blood growth hormone decreased 6
SANDOSTATIN LAR DEPOT Carcinoid syndrome 6
SANDOSTATIN LAR DEPOT Catheter site infection 6
SANDOSTATIN LAR DEPOT Cerebral haemorrhage 6
SANDOSTATIN LAR DEPOT Coordination abnormal 6
SANDOSTATIN LAR DEPOT Diabetic neuropathy 6
SANDOSTATIN LAR DEPOT Drug administration error 6

Total Records: 1,320     Number of Pages: 66